Skip to content
NBDC Human Database

No datasets in the cart.

Go to the cart

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000841

Type of data
NGS (Exome, RNA-seq)
Access criteria
Controlled-access (Type I)
Total data volume
975 GB
File formats
  • FASTQ
Research
hum0294
Date published
2024-05-29
Date modified
2024-05-29
DDBJ Search
JGAD000841 (opens in a new tab)
JGA Study
JGAS000708 (opens in a new tab)

Analysis method

WES

Materials and participants
esophageal cancer (ICD10: C159): 27 cases
tumor tissue before treatment: 27 samples
non-tumor tissue (blood): 27 samples
  • Health status
    Affected
  • Subject count
    27 (Individual)
Disease
esophageal cancer (C159)
Sample description
DNAs extracted from tumor and matched non-tumor tissues (blood samples)
  • Tissue
    Peripheral blood
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
WES
Target
N/A
Reagent kit
SureSelect Human All Exon V6
Platform
Illumina HiSeq X
Read type
Paired-end
Read length
151 bp
Data use policy
NBDC data sharing policy (JGAP000001)

RNA-seq

Materials and participants
esophageal cancer (ICD10: C159): 28 cases
tumor tissue before treatment: 28 samples
tumor tissue after radiation chemotherapy: 25 samples
tumor tissue after atezolizumab administration: 25 samples
  • Health status
    Affected
  • Subject count
    28 (Individual)
Disease
esophageal cancer (C159)
Sample description
RNAs extracted from tumor tissues
  • Tumor / normal
    Tumor
Sample provider
N/A
Experimental method
RNA-seq
Target
N/A
Reagent kit
TruSeq RNA Exome
Platform
Illumina HiSeq X
Read type
Paired-end
Read length
101 bp
Data use policy
NBDC data sharing policy (JGAP000001)